Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Argatroban Plus R-tPA for Acute Posterior Circulation Infarction
NCT03506009Phase 4Terminated
- Start
- Jul 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of argatroban in posterior circulation infarction (PCS). Started Jul 2018; status: terminated.
02
Drugs
argatroban
03
Conditions
posterior circulation infarction (PCS)
Beyond the preview
Go deeper on NCT03506009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03506009.